Tyra Biosciences (TYRA) Other Accumulated Expenses (2020 - 2026)

Tyra Biosciences' Other Accumulated Expenses history runs 7 years deep, the most recent figure standing at $15.1 million for Q1 2026.

• Quarterly Other Accumulated Expenses rose 33.62% year-over-year to $15.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $15.1 million (up 33.62% YoY) and the FY2025 annual result came in at $16.4 million, up 20.98% from the prior year.
• Other Accumulated Expenses was $15.1 million for Q1 2026 at Tyra Biosciences, down from $16.4 million in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $16.4 million in Q4 2025 and bottomed at $2.3 million in Q1 2023.
• A 5-year average of $8.4 million and a median of $8.4 million in 2024 frame the typical range for Other Accumulated Expenses.
• Peak annual rise in Other Accumulated Expenses reached 194.11% in 2023, while the deepest fall reached 34.09% in 2023.
• Tyra Biosciences' Other Accumulated Expenses stood at $4.4 million in 2022, then surged by 135.3% to $10.4 million in 2023, then soared by 30.81% to $13.6 million in 2024, then gained by 20.98% to $16.4 million in 2025, then slipped by 8.02% to $15.1 million in 2026.
• Business Quant data shows TYRA's Other Accumulated Expenses at $15.1 million in Q1 2026, $16.4 million in Q4 2025, and $13.4 million in Q3 2025.